Skip to content

Clinical trials

Phase 2/3 Pulmonary Embolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Phase: Phase 2/3 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20061
20071
20081
20091
20121
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott RDx Cardiometabolic1
Bristol-Myers Squibb1
Instituto Mexicano del Seguro Social1
Intermountain Health Care, Inc.1
Mary Knudson, M.D.1
Ministry of Health, Spain1
Red Cross Hospital Beverwijk1
University Of Perugia1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism9
Venous Thrombosis6
Venous Thromboembolism3
Thromboembolism2
Ankle Fractures1
Atherosclerosis1
Atrial Fibrillation1
Heart Failure1
Inflammation1
Ventricular Dysfunction, Right1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.